Androgen Receptor Luciferase Reporter Lentivirus

Androgen Receptor Luciferase Reporter Lentivirus
Item number Size Datasheet Manual SDS Delivery time Quantity Price
BPS-78763 1 ml (499 µl x 2) - -

3 - 15 business days*

1,417.00€
 
Androgen Receptor Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G... more
Product information "Androgen Receptor Luciferase Reporter Lentivirus"
Androgen Receptor Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce most mammalian cells, including primary and non-dividing cells. These viruses contain a firefly luciferase reporter driven by multiple copies of androgen response element (ARE) located upstream of the minimal TATA promoter. The lentiviruses also contain a puromycin selection marker (Figure 1). After transduction, the cellular androgen receptor signaling pathway can be monitored by measuring the luciferase activity. This product has been validated by testing the response to 5alpha-Dihydrotestosterone (5-DHT) of the transduced prostate cancer cell lines 22Rv1 and CWR-R1ca, but not LNcaP.
Keywords: androgen, AR, Dihydrotestosterone, DHT, prostate cancer, conditional luciferase reporter, NR3C4, castration, Dihydrotestosterone receptor,
Supplier: BPS Bioscience
Supplier-Nr: 78763

Properties

Application: Modulator screening/characterization, cell pool/stable cell line generation

Handling & Safety

Storage: -80°C
Shipping: -80°C (International: -80°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Androgen Receptor Luciferase Reporter Lentivirus"
Write a review
or to review a product.
Viewed